Cargando…
Randomised, open-label, multicentre trial comparing haemodialysis plus haemoperfusion versus haemodialysis alone in adult patients with end-stage renal disease (HD/HP vs HD): study protocol
INTRODUCTION: Haemodialysis (HD) is the cornerstone treatment for patients with end-stage renal disease (ESRD). However, highly protein bound or large molecular weight uremic toxins such as phenolic and indolic compounds and homocysteine, which are associated with adverse outcomes such as cardiovasc...
Autores principales: | Lu, Wei, Jiang, Geng-Ru |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6067402/ https://www.ncbi.nlm.nih.gov/pubmed/30056391 http://dx.doi.org/10.1136/bmjopen-2018-022169 |
Ejemplares similares
-
Standardised outcomes in nephrology – Haemodialysis (SONG-HD): study protocol for establishing a core outcome set in haemodialysis
por: Tong, Allison, et al.
Publicado: (2015) -
Multicentre, observational, retrospective cohort of hyperkalaemia burden at haemodialysis facility-level in China: the Visualize-HD study protocol
por: Zhao, Xinju, et al.
Publicado: (2023) -
Dietary Phosphorus, Its Sources, and Mortality in Adults on Haemodialysis: The DIET-HD Study
por: Su, Guobin, et al.
Publicado: (2022) -
Treatment for severe COVID-19 with a biomimetic sorbent haemoperfusion device in patients on haemodialysis
por: Sandoval, Diego, et al.
Publicado: (2021) -
ACCESS HD pilot: A randomised feasibility trial Comparing Catheters with fistulas in Elderly patientS Starting haemodialysis
por: Quinn, Robert, et al.
Publicado: (2016)